Literature DB >> 13793311

Tofranil-treatment of endogenous depressions.

H Andersen, E S Kristiansen.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; TRANQUILIZING AGENTS/therapy

Mesh：

Substances：

Year:  1959        PMID： 13793311     DOI： 10.1111/j.1600-0447.1959.tb07529.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  6 in total

1.  Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.

Authors:  J S Duncan; S D Shorvon; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

2.  Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.

Authors:  Filippo Bogetto; Silvio Bellino; Raffaele Bonatto Revello; Luca Patria
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Withdrawal phenomena associated with antidepressant and antipsychotic agents.

Authors:  S C Dilsaver
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

4.  [ON THE METHODOLOGY OF RESEARCH ON ANTIDEPRESSIVE DRUGS WITH SPECIAL REFERENCE TO IMIPRAMINE (TOFRANIL) AND DESMETHYLIMIPRAMINE (PERTOFRAN)].

Authors:  H J HAASE; H KOESTER; M KOENIG; A BLEKER
Journal:  Arch Psychiatr Nervenkr       Date:  1963-09-18

Review 5.  Antidepressant discontinuation syndromes.

Authors:  P M Haddad
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

6.  The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read.

Authors:  Sameer Jauhar; Joseph Hayes
Journal:  Addict Behav       Date:  2019-01-23       Impact factor: 4.591
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.